Sir Andrew P. Witty is the CEO of UnitedHealth Group, one of the biggest healthcare companies globally. He took on this role in 2021 after successfully leading Optum, a key part of UnitedHealth. Before that, he was the CEO of...

Sir Andrew P. Witty is the CEO of UnitedHealth Group, one of the biggest healthcare companies globally. He took on this role in 2021 after successfully leading Optum, a key part of UnitedHealth. Before that, he was the CEO of GlaxoSmithKline, where he spent over three decades in various leadership roles. Witty was knighted in 2012 for his contributions to the economy and the pharmaceutical field in the U.K. His leadership during the COVID-19 pandemic was notable as he co-led a global vaccination effort with the WHO. Witty's annual salary is $1.5 million, but he also has a significant performance-based bonus structure which shows he is tied to the company's success. By 2024, his stock holdings in UnitedHealth are valued at over $58 million. His strategy focuses on aligning executive compensation with company performance, linking his wealth closely to the firm's results. With his extensive experience and background, Witty aims to drive UnitedHealth Group toward a bright future, leveraging healthcare innovation and comprehensive services.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

5. Other UnitedHealth Group CEOs

U

Sir Andrew P. Witty

CEO of UnitedHealth Group

Education

B.A. from the University of Nottingham

Field of Expertise

Healthcare & Life Sciences - Pharmaceuticals

Sector of Economy

Healthcare

Born

January 22, 1966 - 59 years ago

CEO of UnitedHealth Group for

4 years 2 months (Feb 2021 - Present)

Previous Experience

CEO of GlaxoSmithKline

Rivals

Competitors/colleagues of Sir Andrew P. Witty

H

Samuel N. Hazen

CEO of HCA Healthcare

2023 Compensation

Stock

$24.94M

Salary

$1.51M

Bonus

$5.03M

Other

$577.42K

Total Holdings

$24.51M

M

Joseph M. Zubretsky

CEO of Molina Healthcare

2023 Compensation

Stock

$1.15M

Salary

$1.10M

Bonus

$2.04M

Other

$87.75K

Total Holdings

$110.57M

M

August J. Troendle

Founder and CEO of Medpace Holdings, Inc.

2023 Compensation

Stock

$0.00

Salary

$825.00K

Bonus

$814.42K

Other

$17.33K

Total Holdings

$1.76B

A

Richard F. Pops

CEO of Alkermes

2023 Compensation

Stock

$0.00

Salary

$1.18M

Bonus

$1.41M

Other

$16.50K

Total Holdings

$47.82M

J

Joaquin Duato

CEO of Johnson & Johnson

2023 Compensation

Stock

$0.00

Salary

$1.58M

Bonus

$3.65M

Other

$241.99K

Total Holdings

$61.93M

C

Sarah M. London

CEO of Centene

2023 Compensation

Stock

$0.00

Salary

$1.40M

Bonus

$2.79M

Other

$285.34K

Total Holdings

$40.36M

Holdings

See how much did Sir Andrew P. Witty make over time.

As the CEO of UnitedHealth Group, Sir Andrew Witty's holdings reflect his commitment to the company. By 2024, his stock investments in UnitedHealth reached over $58 million, significantly growing from previous years. Witty has made strategic stock option grants, emphasizing...

As the CEO of UnitedHealth Group, Sir Andrew Witty's holdings reflect his commitment to the company. By 2024, his stock investments in UnitedHealth reached over $58 million, significantly growing from previous years. Witty has made strategic stock option grants, emphasizing long-term performance. His wealth primarily comes from these stock holdings, which have seen increased value alongside the company's growth. This high level of investment highlights his confidence in UnitedHealth's direction and his interest in driving its success. Having been granted performance shares and options over the years, he has a vested interest in the company's results, making his financial future closely linked to that of UnitedHealth.

Total Stock Sold

$13.43M

UNH

$13.43M

27,536 UNH shares

What if they kept their stock?

If Sir Andrew P. Witty didn't sell their stock, today they would have:
Extra UNH27,536 shares worth $6.83M.
This is -49.15% and $6.60M less than what they got when they sold the stock.

Insider Trading

See recent insider trades of Sir Andrew P. Witty.

UNH

114.126 shares

UNH

Dec 17, 2024

Received

UNH

95.984 shares

UNH

Sep 24, 2024

Received

UNH

110.592 shares

UNH

Jun 25, 2024

Received

UNH

99.389 shares

UNH

Mar 19, 2024

Received

UNH

33,823 shares

UNH

Feb 21, 2024

Received

UNH

86.092 shares

UNH

Dec 12, 2023

Received

UNH

100.456 shares

UNH

Sep 19, 2023

Received

UNH

$2.02M

UNH at $506.19/share

Jul 19, 2023

Sale

UNH

99.672 shares

UNH

Jun 27, 2023

Received

UNH

$3.00M

UNH at $487.49/share

Apr 27, 2023

Sale

Compensation History

See how much did Sir Andrew P. Witty make over time.

Sir Andrew Witty's compensation at UnitedHealth Group includes a base salary of $1.5 million and performance bonuses that can significantly increase his total pay. In 2023, he received a total of $3.28 million, which included a $1.8 million bonus tied to the company's performance in areas like revenue growth and employee satisfaction. This performance-driven compensation reflects UnitedHealth's philosophy of linking executive pay to long-term company results. In 2021, his total compensation peaked at over $18 million, influenced by large stock awards that vested based on meeting performance targets. This structure encourages Witty to focus on sustainable growth, aligning his financial interests with those of shareholders.

Year

2023

Total Compensation

$4.30M

Salary

$1.50M

Board Justification

The compensation philosophy emphasizes aligning executive pay with long-term performance and shareholder value, with a significant portion of compensation tied to performance-based incentives.

Bonus

$1.80M

Board Justification

The annual cash incentive award was based on performance metrics including revenue, operating income, cash flow from operations, and employee engagement, with actual awards reflecting 60% of the target due to performance results.

Other

$0.00

Board Justification

Restricted Stock

$1.00M(22.81K Performance Shares)

Board Justification

The stock compensation awarded in 2023 consisted of performance shares that vested based on the achievement of long-term performance goals over a three-year period.

Performance Metrics

The performance metrics for 2023 included revenue growth, operating income growth, cash flow from operations, and employee engagement metrics.

Other UnitedHealth Group CEOs

Here are other CEOs of UnitedHealth Group

David S. Wichmann

Ex-CEO of UnitedHealth Group

September 2017 - February 2021